Navigation Links
Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report
Date:3/30/2016

PUNE, India, March 30, 2016 /PRNewswire/ --

As per a new report, "Hepatitis C Virus Market: 2016 Edition," the demand for HCV will be driven by comfort of reimbursement, growth in the number of patients, smaller period of drug treatment, increasing healthcare expenditure and treatment of warehoused patients. Some of the noteworthy trends and developments of this industry are launch of interferon free regimen and development of new products. However, the expansion of HCV market is hindered by regulatory risks, patent risk, risk associated with drug development and increased competition.

The Global Hepatitis C Virus (HCV) Market Report: 2016 Edition research of 60 pages with 47 Charts and 12 Tables, 4 company profiles is now available in the pharmaceuticals segment of MarketReportsOnline.com at http://www.marketreportsonline.com/451810.html.

There was no proper therapy for HCV before 2010 but the coming of therapies like Sovaldi and Harvoni by Gilead and Viekira Pak by AbbVie has improved the scenario. Also the steps taken like proper blood screening is also helping in identifying the patients.

Company Coverage of Hepatitis C Virus (HCV) Market: Gilead Sciences , AbbVie, Johnson & Johnson And Bristol-Myers Squibb.

The key factors which are anticipated to drive HCV market include medical reimbursement because of the therapy being very costly, growth in the number of patients, relatively smaller period of drug treatment from before, treatment of the warehoused patients who were waiting for a better therapy and pricing discounts and better regimens because of the increased competition. Some of the significant developments of this HCV market include launch of the interferon free regimen and development of products like Sovaldi, Harvoni and Viekira Pak and the newly identified and diagnosed patients. However, the challenges to be faced ahead is more number of patients asking for reimbursement, increasing competition leading to price cutting, risk associated with drug development and regulatory risk.

Order a copy of this Global HCV Market research report at http://www.marketreportsonline.com/contacts/purchase.php?name=451810.

This report offers a comprehensive analysis of the HCV market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global HCV market is reined by few major players namely Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.

Many new therapies are under clinical trials for achieving more efficiency and cure rate. HCV mainly spreads through blood transfusion and poorly sterilized medical equipments resulting in liver cirrhosis and even leading to liver failure. The main reason that many patients go undiagnosed and not aware of the infection is because it affects very slowly and its symptoms take years to be recognized but today initiatives like proper blood screening has helped in recognizing more patients. Regular alcohol consumption and taking of drugs are also the reasons for getting caught by the infection. Many people use to skip the therapy till some years back because of long duration of treatment and being very costly but the market is increasing due to the coming of more effective therapies and reimbursement policies.

The Global Hepatitis C Virus (HCV) Market Report: 2016 Edition presents an in-depth analysis of the global industry along with a focus on all major regions. A thorough analysis has been conducted on key market players covering their business overview, product portfolio, financial overview and business strategies.

Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.

On a similar note, the Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2016 market research report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Read more at http://www.marketreportsonline.com/440271.html .

About Us:  

MarketReportsOnline.com comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com



'/>"/>
SOURCE Market Reports Online
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Knee Cartilage Repair Market Projected to Reach US$ 2.7 Billion Globally in 2023: Transparency Market Research
2. Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results
3. Peripheral Neuropathy (Sensory) Market Pipeline Global Review H2 2015
4. Global Dialysis Equipment Market Report - Trends, Technologies & Opportunities 2015-2020 - Key Vendors: Diaverum, Asahi Kasei Medical, AngioDynamics
5. Global Medical Robots Market 2016 Emerging Trends and 2021 Forecasts
6. Clinical Trials of Joint Pain Market Reviewed Globally for H1 2016
7. Global Melanoma Partnering Deals and Agreements Report 2016
8. Global Drug Addiction Partnering Deals and Analysis 2010-2016
9. Global Companion Diagnostics Market Analysis 2015-2020 - Trends, Technologies & Opportunities Report - Key Vendors: Qiagen, Roche, Cypher Genomics
10. Global Biosimilars Market Analysis 2015-2020 - Trends, Technologies & Opportunities Report - Key Vendors: Novaritis, Mylan, Ranbaxy
11. Global Home Healthcare Market to Account for US$303.60 Bn by 2020 With North America at Forefront: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... DUBLIN , Mar. 29, 2017 ... "Intraoperative Neuromonitoring (IONM) Market Size & Forecast By Type (Insource ... - 2025" report to their offering. ... The global Intraoperative ... by 2025. The intraoperative neuromonitoring market is anticipated to witness ...
(Date:3/29/2017)... March 29, 2017 Global intravenous (IV) iron and ... by 2021, growing at a CAGR of 5%. ... a doctor to treat anemia or other iron deficiencies. Oral ... the body. However, in some cases, oral administrations are not ... intravenous (IV) iron therapy comes into the picture. ...
(Date:3/29/2017)... 29, 2017 Today, CVS Health officials (NYSE: ... , Department of Public Health Director Gerd Clabaugh ... in announcing the availability of the opioid overdose-reversal medicine ... Iowa.  CVS Health has established a standing order with physicians ... to expand access to the medication in the state.   ...
Breaking Medicine Technology:
(Date:3/30/2017)... Durham, NC (PRWEB) , ... March 30, 2017 ... ... professionals, will host the live audio conference “ Preventing Hospital Readmissions Through Discharge ... April 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up ... year develop other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic ... focus on finding more effective treatment options, the San Diego Gamma Knife Center ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS ... Medical Center will serve as the official title sponsor of the Baltimore Women’s Classic, ... 2017, thousands of women will walk or run the course around the Baltimore Inner ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... 29, 2017 , ... Patients interested in receiving quick and ... Jamie Cameron, with or without a referral. The FASTBRACES system is valued for ... each patient’s case, treatment with the FASTBRACES system could be completed in 120 ...
Breaking Medicine News(10 mins):